research papers
Quadruple space-group ambiguity owing to rotational and translational
in human liver fructose-1,6-bisphosphataseapRED, Therapeutic Modalities, F. Hoffmann-La Roche, 4070 Basel, Switzerland
*Correspondence e-mail: markus.rudolph@roche.com
Fructose-1,6-bisphosphatase (FBPase) is a key regulator of gluconeogenesis and a potential drug target for type 2 diabetes. FBPase is a homotetramer of 222 symmetry with a major and a minor dimer interface. The dimers connected via the minor interface can rotate with respect to each other, leading to the inactive T-state and active R-state conformations of FBPase. Here, the first of human liver FBPase in the R-state conformation is presented, determined at a resolution of 2.2 Å in a tetragonal setting that exhibits an unusual arrangement of (NCS) elements. Self-Patterson function analysis and various intensity statistics revealed the presence of pseudo-translation and the absence of The is P41212, but was also possible in space groups P43212, P4122 and P4322. All solutions have the same arrangement of three C2-symmetric dimers spaced by 1/3 along an NCS axis parallel to the c axis located at (1/4, 1/4, z), which is therefore invisible in a self-rotation function analysis. The solutions in the four space groups are related to one another and emulate a body-centred lattice. If all NCS elements were crystallographic, the would be I4122 with a c axis three times shorter and a single FBPase subunit in the I4122 is a minimal, non-isomorphic of the four primitive tetragonal space groups, explaining the space-group ambiguity for this crystal.
Keywords: pseudo-symmetry; fructose-1,6-bisphosphatase; allosteric regulation; conformational change; glucose metabolism.
PDB reference: human liver FBPase, 5ldz
1. Introduction
Glucose is the main energy source for the brain. In mammals, blood glucose homeostasis is maintained mainly by the balance of catabolic glycolysis on the one hand and (with respect to glucose) anabolic glycogenolysis and gluconeogenesis on the other. Increased glucose production is the predominant cause of high blood glucose levels in type 2 diabetes, which can lead to kidney, neurological and cardiovascular damage. In humans, high glucose levels arise from excessive gluconeogenesis in the liver rather than from glycogenolysis of hepatic glycogen stores. Fructose 1,6-bisphosphatase (FBPase) is a major control point in gluconeogenesis, catalyzing the hydrolysis of fructose 1,6-bisphosphate (F-1,6-P2) to fructose 6-phosphate (F6P) and inorganic phosphate (Fig. 1a). This step in gluconeogenesis is synergistically down-regulated by fructose 2,6-bisphosphate (F-2,6-P2) and AMP, which bind to the active site and an allosteric site of FBPase, respectively. While the cellular level of AMP seems to be constant (Xue et al., 1994), the concentration of F-2,6-P2 is controlled by the glucagon-sensitive enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. A small change in the F-2,6-P2 concentration thus has a large effect on AMP-mediated FBPase inhibition. During times of glucose demand, F-2,6-P2 levels are reduced, leading to increased activity of FBPase. An aberrant up-regulation of gluconeogenesis, especially when coupled with decreased uptake and metabolism of glucose from the blood into cells, may lead to type 2 diabetes (Visinoni et al., 2012). Inhibition of the liver isoform of FBPase (hlFBPase; the other isoform being the muscle isoform) is therefore an attractive avenue for disease treatment.
FBPases are homotetramers with D2 symmetry composed of 37 kDa subunits. Each subunit contains one active and one allosteric site (Fig. 1b). The subunits are labelled C1–C4 and form two functional dimers: C1/C2 and C3/C4. The active site of the C1 subunit is near the C1/C2 interface, while its AMP-binding site is near the C1/C4 interface. The C1/C2 and C3/C4 dimers can rotate with respect to each other. In the enzymatically active R state of the hlFBPase tetramer, the dimers are little, if at all, rotated and the protomers are therefore arranged as an almost planar rectangle. In this conformation, a loop important for catalysis (residues 50–72, also termed the `dynamic loop') may either be disordered or folds onto the active site, allowing F-1,6-P2 to be hydrolyzed (Choe et al., 1998). The hydrolysis reaction requires the presence of Mg2+ or Zn2+ ions. In contrast, binding of the allosteric regulator AMP facilitates rotation of the dimers by ∼15°, leading to detachment of the catalytic loop (Choe et al., 1998). This T state of FBPase is the catalytically inactive conformation.
Structural information on FBPases is available for porcine (no isoforms), rabbit, human liver and human muscle FBPases in the T state (Ke, Zhang et al., 1990; Gidh-Jain et al., 1994; Iversen et al., 1997; Barciszewski et al., 2016) and for porcine and human muscle FBPase in the R state (Ke et al., 1989; Ke, Zhang et al., 1990, Ke, Liang et al., 1991; Ke, Zhang et al., 1991; Choe et al., 1998, 2000; Xue et al., 1994; Weeks et al., 1999; Barciszewski et al., 2016). Crystal structures of porcine FBPase in complex with various ligands established that the R and T states differ from each other by an ∼15° rotation of the dimers about the principal molecular axis (Ke, Zhang et al., 1990; Choe et al., 1998). Pushing the FBPase conformational equilibrium towards the inactive T state by allosteric inhibitors that mimic AMP is a well explored route for glucose-level modulation in the blood (Wright et al., 2003; von Geldern et al., 2006; Dang et al., 2007, 2008, 2011; Erion et al., 2005, 2007; Lai et al., 2006; Kitas et al., 2010; Hebeisen et al., 2011; Tsukada et al., 2009, 2010). AMP-site inhibitors connected by a suitable linker to simultaneously bind the AMP sites from two adjacent subunits in the FBPase tetramer gain 105 times in potency compared with monomeric inhibitors (Hebeisen et al., 2008). In addition, a second allosteric site at the C1/C4 interface that is also close to the C1/C2 interface, and hence common to all subunits, has been exploited for inhibitor design (Wright et al., 2002; Choe, Nelson et al., 2003).
For human liver FBPase, currently only T-state structures have been published. Here, we have determined the structure of hlFBPase in a novel primitive tetragonal crystal form in the active R state. An interesting combination of rotational NCS (rNCS) and translational NCS (tNCS) allows P41212. Here, we describe how the rNCS and tNCS emulate pseudo-symmetry and discuss the of hlFBPase in light of the R/T transitions in the pig and human FBPase enzymes.
in four different space groups comprising two enantiogenic pairs. The combination of a twofold rNCS at a special position with tNCS of vulgar fractions of a unit-cell length leads to pseudo-body-centred tetragonal symmetry, but the true is2. Materials and methods
2.1. Protein purification, crystallization and data collection
Human liver FBPase 1 cDNA (NM_000507) was purchased from Origene, cloned into pET-21a via the EcoRI/NdeI sites and produced in Escherichia coli BL21 (DE3). Cells were suspended in 20 mM Tris–HCl pH 7.5, 1 mM EDTA, 1 mM DTT and disintegrated using a French press. The soluble extract was heated to 65°C for 5 min. The supernatant after centrifugation was applied onto a Macro-Prep High Q column (Bio-Rad) equilibrated in the above buffer. The flowthrough containing FBPase activity was applied onto a Macro-Prep High S column (Bio-Rad) equilibrated with 20 mM HEPES–NaOH pH 7.2, 1 mM DTT. hlFBPase was eluted with an NaCl gradient and fractions containing active FBPase were pooled. on Sephacryl S200 equilibrated in 20 mM Tris–HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM DTT completed the purification. For optimal activity in enzymatic reactions, hlFBPase was dialyzed against 10 mM potassium/sodium phosphate pH 7.4, 2 mM MnCl2, 5 mM MgCl2, 2 mM ZnCl2.
Crystals were obtained in a micro-batch setup by mixing 0.5 µl volumes of 22.5 mg ml−1 hlFBPase in 10 mM potassium/sodium phosphate pH 7.4, 2 mM MnCl2, 5 mM MgCl2, 2 mM ZnCl2, 0.5 mM F-2,6-P2 with reservoir solution consisting of 0.1 M Tris–HCl pH 8.5, 2 M ammonium sulfate. Crystals were cryoprotected and a data set was collected to a resolution of 2.2 Å (Table 1) from a cryocooled single crystal at 100 K on beamline PX-II at the Swiss Light Source using a wavelength of 0.979 Å and a MAR CCD detector of 165 mm diameter. Data were integrated and scaled using the HKL package (Otwinowski & Minor, 1997) and SADABS (Bruker), respectively. Indexing and integration was possible in primitive tetragonal, but not I-centred. settings, leading to unit-cell parameters of a = 121.5, c = 316.6 Å (Table 1). The likely presence of fourfold and twofold screw axes was established by analysis of the systematically absent reflections from data processed in P422 (Table 2). As discussed in §2.3, the true is P41212 and the presence of pseudo-translation (Fig. 2a) emulates I-centred symmetry. Assuming six FBPase molecules in the the Matthews coefficient (Matthews, 1968) is 2.8 Å3 Da−1 with a solvent content of 56%.
‡The 100% criterion was calculated using SFTOOLS from CCP4 (Winn et al., 2011) and represents the resolution in Å of a 100% complete hypothetical data set with the same number of reflections as the measured data. §R values and CC1/2 are defined in Diederichs & Karplus (1997) and Karplus & Diederichs (2012), respectively, and were calculated with PHENIX (Zwart, Afonine et al., 2008). Rmerge for the low-resolution shell (39.8–6.1 Å) is 6.0%, indicating that P422 is the correct symmetry. ¶E values, moments and L values are calculated using PHENIX (Zwart, Afonine et al., 2008) for acentric reflections in the resolution range 10–3.5 Å. Values in parentheses are the expected values for untwinned and perfectly twinned data, respectively. |
|
2.2. Data analysis
The data indexed readily and produced reasonable scaling statistics in a primitive 422 lattice (Table 1). To establish the were analyzed. While no reflections were measured along the h axis, analysis of the 0k0 reflections is consistent with the presence of a 21 screw axis. Likewise, the presence of only l = 4n reflections is consistent with both a 41 and a 43 screw axis, suggesting P41212 or its as possible space groups (Table 2). Plots of the self-rotation function calculated with XPREP (Bruker) in P422 are unremarkable, displaying the expected fourfold (κ = 90°; not shown) and the mutually perpendicular arrangement of the fourfold and twofold axes in the κ = 180° section (Fig. 2b). Should noncrystallographic rotational symmetry be present, these axes would have to run parallel to a crystallographic axis. The u = 0 and u = 1/2 sections of the native (Fig. 2a) contain three significant peaks of >20% of the origin signal at positions (u, v, w) = (1/2, 1/2, 1/6), (0, 0, 1/3) and (1/2, 1/2, 1/2). The presence of strong pseudo-translation manifests itself in a high value for the standard deviation of the mean normalized structure-factor amplitude E, 〈|E2 − 1|〉, which is 1.152 but should be 0.736 for chiral space groups in the absence of (Table 1), and also in the cumulative intensity distribution as reported by TRUNCATE from CCP4 (Winn et al., 2011; Fig. 2c). If the special position at (1/2, 1/2, 1/6) were crystallographic, no intensities would be measurable for a subset of reflections, while in the case of certain reflections would be weak. Querying the structure-factor formula for that result in amplitudes |Fhkl| = 0 requires
This leads to the condition exp[πi(h + k + l/3)] = −1, which is fulfilled by 1/6 of all reflections in the data set that obey h + k + l/3 = 2n + 1, with n being an integer. While these ∼20 000 reflections are indeed weak, they are not absent, but have an 〈I〉/〈σ(I)〉 value of 2.0 (Table 2). For comparison, the h + k + l/3 = 2n reflections have correspondingly larger intensities of 〈I〉/〈σ(I)〉 = 19.6, while 〈I〉/〈σ(I)〉 for the whole data set is 11.8 (Table 2). An equivalent reasoning for the weaker Patterson peak at (1/2, 1/2, 1/2) reveals only a slight decrease of 18% in the intensities of reflections h + k + l = 2n + 1 (Table 2) compared with the h + k + l = 2n reflections, in line with the impossibility of indexing the data in an I-centred lattice where reflections h + k + l = 2n + 1 must be absent. Lastly, the vector (0, 0, 1/3) will not change any reflection intensities. The source of the pseudo-translation and pseudo-centring only became clear after (discussed below). Owing to the presence of pseudo-translation and the corresponding strong correlation of some reflection intensities, global statistics that rely on the data following a Wilson distribution are skewed (Table 1). Thus, tests based on the cumulative intensity distribution, the |E2 − 1| value (Fig. 2c) or moments on intensities or structure-factor amplitudes cannot be employed, and the pseudo-translation may mask the presence of (Padilla & Yeates, 2003; Rudolph et al., 2004; Zwart, Grosse-Kunstleve et al., 2008; Read et al., 2013). It is possible in principle that the hlFBPase data belong to Patterson symmetry P4/m with emulating the higher metric symmetry P4/mmm. A test based on local non-twin-related reflection pairs, the L-value (Padilla & Yeates, 2003), which is not influenced by the presence of pseudo-centring provided that suitable reflection pairs are chosen (Sliwiak et al., 2015), shows little deviation from the expected values for untwinned data (Table 1, Fig. 2d), indicating that the hlFBPase data are not twinned. This turned out to be true after (see below).
2.3. Phasing and refinement
P4122, P4322, P41212 and P43212 using Phaser v.2.1.4 (McCoy et al., 2007). FBPase is a homotetramer composed of a dimer of dimers. The C1/C2 dimer of an in-house FBPase structure was used as the search model. When tested separately, all space groups returned a single solution of three dimers with the same overall arrangement, whereby P41212 gave the strongest signal (Table 3). Of note, the latest version of Phaser will use the tNCS information present in the data to automatically select the correct of all four solutions in BUSTER (Blanc et al., 2004) using the same set of test reflections to calculate Rfree indicated P41212 as the correct based on the lowest Rfree value (Table 3). The model in P41212 was rebuilt in Coot (Emsley et al., 2010) and refined using BUSTER. No NCS restraints were applied and each of the six protomers was defined as a TLS group. Loop 22–26 near the AMP-binding site and the catalytic loop 56–70 were not included in the model owing to a lack of electron density. are collected in Table 4. Coordinates and structure factors for hlFBPase have been deposited in the Protein Data Bank (PDB entry 5ldz). Analysis of electron-density maps calculated with anomalous differences and refined phases revealed significant peaks of >5σ that could be either Zn2+ or Mn2+. At the wavelength of data collection (0.979 Å), the calculated values for zinc and manganese are f′′(Zn) = 2.5 e and f′′(Mn) = 1.3 e, pointing to zinc rather than manganese as the element present. As discussed in §3.4, owing to the 3.3-fold more frequent occurrence of trigonal bipyramidal coordination of zinc versus manganese in the Cambridge Structural Database (CSD) and previous FBPase crystal structures containing Zn2+ rather than Mn2+, the former ion was modelled at these positions (Fig. 8), although a mixture of Zn2+ and Mn2+ cannot be completely excluded.
was performed to phase the hlFBPase data in the four space groups
‡TF, translation function. §LLG, log-likelihood gain. |
‡Cruickshank diffraction-component precision index based on the R value (Blow, 2002). §The maximum-likelihood-based phase error was calculated with PHENIX (Zwart, Afonine et al., 2008). ¶Calculated using PHENIX (Zwart, Afonine et al., 2008). ††The MolProbity score should approach the high-resolution limit (Chen et al., 2010). ‡‡ Clashscore is defined as the number of unfavourable all-atom steric overlaps ≥0.4 Å per 1000 atoms (Word et al., 1999). |
3. Results and discussion
3.1. Combination of rNCS and tNCS in FBPase
The three dimers in the A, B, C and D, and the second (EFE′F′) completed by crystal symmetry (Fig. 3a). Alignment of molecular symmetry axes with crystallographic elements is quite common for FBPases from different organisms. 30 out of 90 structures in the PDB, including pig, rabbit and human FBPases, crystallized in five different space groups and contain only a single subunit in the The tetramer is constructed by operations (Choe et al., 1998, 2000; Weeks et al., 1999; Choe, Iancu et al., 2003; Choe, Nelson et al., 2003; Iancu et al., 2005; Shi et al., 2013; Gao et al., 2013; Barciszewski et al., 2016). 50 more FBPase structures in three different space groups have a C1/C2 dimer in the and the tetramer is also completed by Others, such as pig FBPase in P212121, contain a complete tetramer with the shortest molecular twofold axis almost aligned with the b axis (Ke, Liang et al., 1991). The case of hlFBPase is a combination of these examples. One complete tetramer is aligned parallel to the c axis. An additional C1/C2 dimer is also aligned with the c axis and completed to a tetramer by (Fig. 3a).
of hlFBPase form one and a half FBPase tetramers, with the first tetramer composed of protomersRearrangement of the three hlFBPase C1/C2 dimers reveals a twofold rNCS axis located at fractional coordinates (1/4, 1/4, z) with the dimers spaced by 1/3 along z (Fig. 3b). This twofold axis runs parallel to the crystallographic fourfold, explaining the unremarkable self-rotation function (Fig. 2b). Since a twofold axis at (1/4, 1/4, z) is equivalent to a (−x + 1/2, −y + 1/2, z), combination of this NCS operator with those of the primitive tetragonal space groups of Patterson symmetry P4/mmm generates eight instances of a (1/2, 1/2, 1/2) translation. The pseudo-body-centring introduced thereby leads to the observed at (1/2, 1/2, 1/2). However, the height of this vector is only 24% of the origin peak (Fig. 2a), ruling out an I-centred lattice. Calculation of the native at different high-resolution limits shows that this peak reaches 80% of the origin peak at 12 Å, further showing that the I-centring is pseudo. The vector at (1/2, 1/2, 1/2) combines with the pseudo-translation of (0, 0, 1/3) along the NCS axis to form a strong signal at (1/2, 1/2, 5/6), which is symmetry-related to (1/2, 1/2, 1/6), thus explaining all of the peaks in the native (Fig. 2a).
In the presence of tNCS, an additional et al., 2004). As a of a twinned crystal contains the atomic distance information of both twin domains but no cross-peaks between them, a pseudo-translation vector in a twin should appear twice in the native The prerequisite is that the tNCS vectors are not superimposed by the twin operator. For diffraction data scaled in P4, the potential twin operator emulating pseudo-P422 symmetry (k, h, −l) corresponds to a twofold rotational axis bisecting the ab plane. Unfortunately, since the pseudo-translation vector in hlFBPase is parallel to the rNCS along the c axis, the twin operator would superimpose the tNCS vectors of the twin domains (with the inverse direction), thus not leading to any change in the native Therefore, the potential presence of cannot be tested by analyzing the native Patterson maps in this particular case, and prior to and judging the results based on Rfree (see below), the L-test (Padilla & Yeates, 2003) was the sole statistic on which the absence of in the hlFBPase data was based (Fig. 2c).
test is sometimes possible (Rudolph3.2. The same packing of hlFBPase in four space groups
P4122, P4322, P41212 and P43212 each resulted in a single unique solution with a log-likelihood gain (LLG) of >16 000 (Table 3). The solution in P41212 can be transformed into the P43212 solution by a 90° clockwise rotation about (1/4, 1/4, z) and a shift of −1/3 along z (Fig. 3c). The corresponding transformation into P4122 is the same rotation but with a translation by −7/24 along z (Fig. 3d), and the transformation into P4322 requires a 180° rotation about (1/4, 1/4, z) and a shift of 11/24 along z (Fig. 3e). of hlFBPase in the four space groups led to acceptable Rfree values in all cases, although with a preference for space groups P41212 and P4122 (Table 3). The large cross-correlation coefficients between the phases in all four space groups of 0.81–0.84 confirm the notion that all solutions essentially describe the same situation. The question arises how packing in two enantiogenic space-group pairs is possible or, in other words, how the hlFBPase can introduce a twofold axis and thereby generate additional fourfold screw axes of both hands (Fig. 3).
in the four space groupsThe handedness of the fourfold screw axis is a distinguishing feature of the enantiomorphic pairs P41212/P43212 and P4122/P4322. Thus, the arrangement of protomers in the must enable both hands. Fig. 4 shows the molecular-replacement solution for P41212 with the six individually coloured protomers simplified by the position of their centres of mass. Half of the molecules around a fourfold axis at (1/2, 0, z) follow a left-handed `41/3' axis, i.e. a fourfold screw axis with three complete turns along the each molecule is shifted by 1/12 with respect to its predecessor (Fig. 4a). A subset of molecules within this group follows a canonic 41 axis. Likewise, the other half of the molecules around the crystallographic fourfold screw axis also follow a left-handed `41/3' axis, with a subset following a canonic 41 axis (Fig. 4b). Thus, both types of handedness are present in both subsets, explaining the ambiguity along the fourfold axis. Similar considerations hold for the twofold or 21 axis parallel to the crystallographic a (and b) axis in the pairs P41212/P4122 and P43212/P4322. Accordingly, the four molecular-replacement solutions display virtually identical packing (Figs. 5a and 5b).
3.3. Requirements for and breakdown of the I-centring in hlFBPase
The presence of a twofold axis at (1/4, 1/4, z) is a distinguishing feature of the I4122 lattice compared with space groups with P4/mmm Patterson symmetry. In hlFBPase, a twofold rNCS axis is present at this position that would in principle allow I4122 as a higher symmetry I4122 is a minimal non-isomorphic for the four space groups P4122, P4322, P41212 and P43212, further corroborating why was possible in all of them. A 21 screw axis at (1/4, 1/4, z) would generate an I422 lattice, but the corresponding primitive space groups would be P422/P4212 or P4222/P42212, which are not supported by an analysis of (Table 2), and which also did not deliver molecular-replacement solutions. Reflections with l ≠ 4n are absent, identifying a 41/43 screw axis in the hlFBPase data, which leaves I4122 as the sole option. A caveat for interpreting is the possibility of pseudo-translation changing reflection intensities along the reciprocal axes, which might apply to hlFBPase owing to the translational component of ∼1/3 along the c axis. As mentioned above, the subset that is strongly altered by the vector (1/2, 1/2, 1/6) is (h + k + l/3), and (0, 0, l) reflections with reflection condition l = 4n for 41 or 43 axes that are a part of this subset must have l = 12n. Because these reflections are even, they are not eliminated by the pseudo-translation but are slightly stronger [〈I〉/〈σ(I)〉 = 10, N = 11]. An alternative approach is to calculate the reflection condition for absences owing to the (0, 0, 1/3) vector for reflections along the l axis. The resulting subset (0, 0, 3n + 3/2) is impossible, i.e. this pseudo-translation vector does not alter any (0, 0, l) reflection intensities. Taken together, the systematic absence analysis for the possible higher symmetry is unaffected by the pseudo-translation. Thus, if the rNCS at (1/4, 1/4, z) were crystallographic, I4122 would result. The question remains as to why hlFBPase does not form an I-centred lattice.
The two conditions that need to be fulfilled for I-centring are a crystallographic twofold at (1/4, 1/4, z) and a pure translation of (0, 0, 1/3). In a case where the translation were exactly 1/3, the three copies of the hlFBPase dimer would be identical and the c* axis would triple (the original c axis reduced to 105.5 Å). I4122 with a smaller c axis would harbour only a single protomer in the and crystal symmetry would construct an hlFBPase homotetramer with perfect 222 symmetry, similar to what has been observed with many other FBPase structures (see above). using data forcibly reduced in I4122 with a c/3 axis resulted in a clear and single solution (Z-scores of 11.9 and 27.1 for the rotation and translation functions; overall LLG = 830) with the expected packing (Figs. 5c and 5d). However, this solution could not be refined to an Rfree value of <34%, further corroborating the primitive setting. Table 5 summarizes the geometric relations between the six protomers in the hlFBPase P41212 The r.m.s.d. values between the protomers are of the order of 0.3 Å, mostly because of differences in the conformation of the C-termini and the loop region 142–148. The rotation angles are close to either zero or 180°. Nine out of 15 possible twofold rotation combinations vary between 179.0 and 180.0°, with a mean of 179.6 ± 0.3°. The remaining six cases have rotation components between 0.84 and 1.84°, with a mean of 1.21 ± 0.47°. The translation components along the c axis are almost exactly 1/3 or 2/3 in all cases. By contrast, the translation vectors in the ab plane vary by as much as 4.6% (5.6 Å) from zero or 1/2, indicating that the reason for the breakdown of symmetry, which prohibits an I-centred lattice, is owing to lateral translation of the hlFBPase dimers in the ab plane. A projection of the FBPase dimers along the rNCS axis onto the ab plane confirms this hypothesis: lateral displacements from the rNCS axis are incompatible with this operator being crystallographic (Figs. 6a and 6b). In addition, while a superposition of the two hlFBPase tetramers onto one protomer (blue and orange in Fig. 6c) shows little differences in the face-on orientation (Fig. 6c), a kinked arrangement of dimers is visible when the tetramers are viewed side-on (Fig. 6d) or from the top (Fig. 6e). The directions of the rotation axes for the upper dimers differ significantly by 2.2°, leading to displacements in excess of 2 Å, which is sufficient for the breakdown of body-centred symmetry.
3.4. Apo hlFBPase adopts the R state
The ). The rotation angle of the C1/C2 versus the C3/C4 dimers about the principal molecular axis is 2.9°, which is at the upper end of R-state angles of 1.3 ± 0.9° (n = 36, range 0–3.8°) found in porcine FBPase crystal structures. A significant deviation from co-planarity (2.8, 3.0 and 5.4°) of the subunits has also been observed for three human muscle FBPase (hmFBPase) structures (Shi et al., 2013).
of hlFBPase described here is the first example of the R state of the human liver isoform (Fig. 7Binding of AMP to the allosteric sites induces a conformational change in FBPase from its active R state to its inactive T state (Ke, Thorpe et al., 1990; Choe et al., 1998). In human liver FBPases the average rotation angle of the T state is 14.5 ± 0.4° (n = 15, range 13.9–15.1°), which is very similar to that observed in porcine FBPase T-state structures of 14.2 ± 1.2 (n = 30, range 10.5–17.1°). Three hmFBPase structures have similar rotation angles of 15.6 ± 0.2° (range 15.4–15.7°; Zarzycki et al., 2011; Barciszewski et al., 2016), which would indicate that the amount of rotation in FBPases is generally of the order of 15°. This view has been challenged by a recent hmFBPase structure that showed a cruciform arrangement of the dimers, i.e. a rotation angle of close to 90° (Barciszewski et al., 2016). Since the human muscle and liver FBPase isoforms share only 76.9% sequence identity (89.3% homology) over 337 residues and the muscle isoform has additional functions in the cell, including higher sensitivity of hmFBPase to AMP and its regulation by Ca2+ (Gizak et al., 2012; Pirog et al., 2014), some differences in their R/T transition behaviour might be expected. In solution, porcine FBPase subunits have been shown to exchange on a time scale of a few hours (Nelson et al., 2001), indicating flexibility at the interfaces. Thus, the possibly that the rotation angle of FBPases might sometimes be influenced by crystal-packing effects cannot be discounted entirely.
Although excess F-2,6-P2 was present during crystallization of hlFBPase to facilitate formation of the R state, the electron density does not support the presence of this competitive inhibitor in the active site. Instead, two sulfate ions from the crystallization medium are located in the active site (Fig. 8a). Comparison of hlFBPase with porcine FBPase in complex with F6P and phosphate (Choe et al., 1998) and with porcine FBPase in complex with F-2,6-P2 (Hines et al., 2007) shows that the sulfate ions in hlFBPase are located near the positions of the phosphoryl groups in F6P and F-2,6-P2 (Figs. 8b and 8c, respectively). The sulfate ion mimicking the 6-phosphoryl group is bound in the same manner in all structures by three hydrogen bonds from side chains of two tyrosines and an asparagine. The second sulfate ion in hlFBPase is located halfway between the positions of the inorganic phosphate in the F6P/Pi complex (Fig. 8b; ∼2.7 Å P–P distance) and the 2-phosphoryl group in the F-2,6-P2 complex (Fig. 8c; ∼2.2 Å P–P distance). While for steric reasons the 2′-phosphoryl group in F-2,6-P2 cannot bind to the metal ion, in a total of 11 product complexes the inorganic phosphate is a direct ligand for either Zn2+ or Mg2+. By contrast, the corresponding sulfate ion in hlFBPase is bound to the metal ion via a water molecule, a constellation that has not been observed before in FBPase crystal structures and may reflect a state during catalysis where inorganic phosphate is about to leave the active site after hydrolysis has completed.
Up to three metal ions have been observed in FBPase structures (termed M1–M3; Fig. 8b). The structure of hlFBPase contains a single metal ion at position M1, which based on the crystallization conditions could in principle be Mg2+, Mn2+ or Zn2+. The M1 site in FBPase seems to be rather promiscuous: while Zn2+ was identified in the majority of structures, Mn2+, Mg2+ and Tl+ have also been located at this position. Based on strong OMIT electron density and an anomalous signal of >7 r.m.s.d. (Fig. 8a), Mg2+ could be excluded. Mn2+ appears to be less likely than Zn2+, since it has only half the anomalous signal at the data-collection wavelength (see §2). Also, of hlFBPase with Mn2+ at position M1 led to a smaller average B value for Mn2+ over the six molecules in the compared with the metal-binding atoms (41 Å2 versus 49 Å2), while with Zn2+ yielded average values of 50 Å2 for both sets of atoms. A distinction based on distances, which are similar for Zn2+ and Mn2+ (Harding et al., 2010), was not possible at the resolution of hlFBPase (2.2 Å). The coordination geometries observed in FBPase crystal structures at the M1 site include tetrahedral, octahedral and trigonal bipyramidal. In the majority of cases the M1 site is occupied by a tetrahedrally coordinated Zn2+, reflecting the preferred geometry of this ion. By contrast, the Zn2+ in hlFBPase has trigonal bipyramidal coordination from four acidic side chains and a water molecule (Fig. 8a). A similar trigonal bipyramidal coordination of Zn2+, although tilted with respect to hlFBPase, was observed in the of porcine FBPase in complex with F-2,6-P2 (Hines et al., 2007; Fig. 8c). A search in the CSD for zinc- and manganese-containing compounds revealed only 103 small molecules with an Mn atom in trigonal bipyramidal geometry (0.57%), while a Zn atom in this geometry was present in 498 small-molecule crystal structures (1.87%), further hinting towards a Zn2+ at the M1 site. In conclusion, the M1 metal-binding site of FBPases is structurally versatile and can accommodate several cations in different coordination geometries. No metal ions are present at sites M2 and M3 in hlFBPase. The metal ion at site M3 is coordinated by an aspartate side chain from the catalytic loop (Asp68 in Fig. 8b). Residues 55–70 of the catalytic loop are disordered in the hlFBPase structure, possibly explaining the absence of the other cations.
The allosteric AMP site in hlFBPase is also occupied by a sulfate ion, which mimics the position of the phosphoryl group of AMP (Fig. 8d). The anion is cradled in a classical P-loop followed by an α-helix. A conserved set of hydrogen bonds from the side chain of a threonine and the NH groups of main-chain residues in the P-loop, together with the positive end of the helix dipole and a lysine side chain, neutralize the negative charges of the anion (Figs. 8e and 8f).
4. Conclusions
While a model for the T state of hlFBPase is sufficient for structure-based drug-design purposes, the conformational picture of human liver FBPase has hitherto been incomplete. The structure of hlFBPase in the R state fills this gap. It shows that the R state of hlFBPase is similar to the R states of the rabbit, porcine and human muscle FBPases and that the human liver isoform engages in conformational changes similar in magnitude to those of porcine FBPase. The hlFBPase structure exhibits a number of interesting properties, including a metal ion in a comparatively rare trigonal bipyramidal coordination bound via a water molecule to a sulfate ion that mimics the leaving inorganic phosphate after hydrolysis of the substrate. From a crystallographic point of view, the hlFBPase structure is interesting for its peculiar arrangement of NCS elements, which emulate I-centred symmetry while the true symmetry is primitive with a c axis that is three times longer. A search in the PDB for structures with more than two molecules per in the four space groups P4122, P4322, P41212 and P43212 that exhibit pseudo-translation returned 86 instances with a vector >20% of the Patterson origin peak. Of these, 33 emulate I-centring with a peak at (1/2, 1/2, w), but only three structures, PDB entries 4gqc, 2g6z and 3gfb, have w at rational fractions of the c axis (w = 1/2, w = 1/6 and w = 1/4, respectively). In none of these cases is the rNCS axis at a position to emulate so the case of hlFBPase seems unique at present. However, given the high prevalence of pseudo-symmetry in macromolecular crystal structures of ∼8% (Zwart, Grosse-Kunstleve et al., 2008), similar cases are to be expected.
Acknowledgements
We thank Catherine Joseph for crystallization and the staff at SLS beamline PX II for support during synchrotron data collection. We are grateful to the Phaser developers that the hlFBPase data could be used to improve the algorithms subsequent to and analysis of this case.
References
Barciszewski, J., Wisniewski, J., Kolodziejczyk, R., Jaskolski, M., Rakus, D. & Dzugaj, A. (2016). Acta Cryst. D72, 536–550. CrossRef IUCr Journals Google Scholar
Blanc, E., Roversi, P., Vonrhein, C., Flensburg, C., Lea, S. M. & Bricogne, G. (2004). Acta Cryst. D60, 2210–2221. Web of Science CrossRef CAS IUCr Journals Google Scholar
Blow, D. M. (2002). Acta Cryst. D58, 792–797. Web of Science CrossRef CAS IUCr Journals Google Scholar
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S. & Richardson, D. C. (2010). Acta Cryst. D66, 12–21. Web of Science CrossRef CAS IUCr Journals Google Scholar
Choe, J. -Y., Fromm, H. J. & Honzatko, R. B. (2000). Biochemistry, 39, 8565–8574. CrossRef PubMed CAS Google Scholar
Choe, J.-Y., Iancu, C. V., Fromm, H. J. & Honzatko, R. B. (2003). J. Biol. Chem. 278, 16015–16020. CrossRef PubMed CAS Google Scholar
Choe, J.-Y., Nelson, S. W., Arienti, K. L., Axe, F. U., Collins, T. L., Jones, T. K., Kimmich, R. D., Newman, M. J., Norvell, K., Ripka, W. C., Romano, S. J., Short, K. M., Slee, D. H., Fromm, H. J. & Honzatko, R. B. (2003). J. Biol. Chem. 278, 51176–51183. CrossRef PubMed CAS Google Scholar
Choe, J.-Y., Poland, B. W., Fromm, H. J. & Honzatko, R. B. (1998). Biochemistry, 37, 11441–11450. Web of Science CrossRef CAS PubMed Google Scholar
Dang, Q., Kasibhatla, S. R., Jiang, T., Fan, K., Liu, Y., Taplin, F., Schulz, W., Cashion, D. K., Reddy, K. R., van Poelje, P. D., Fujitaki, J. M., Potter, S. C. & Erion, M. D. (2008). J. Med. Chem. 51, 4331–4339. CrossRef PubMed CAS Google Scholar
Dang, Q., Kasibhatla, S. R., Reddy, K. R., Jiang, T., Reddy, M. R., Potter, S. C., Fujitaki, J. M., van Poelje, P. D., Huang, J., Lipscomb, W. N. & Erion, M. D. (2007). J. Am. Chem. Soc. 129, 15491–15502. CrossRef PubMed CAS Google Scholar
Dang, Q. et al. (2011). J. Med. Chem. 54, 153–165. CrossRef CAS PubMed Google Scholar
Diederichs, K. & Karplus, P. A. (1997). Nature Struct. Biol. 4, 269–275. CrossRef CAS PubMed Web of Science Google Scholar
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. (2010). Acta Cryst. D66, 486–501. Web of Science CrossRef CAS IUCr Journals Google Scholar
Erion, M. D., Dang, Q., Reddy, M. R., Kasibhatla, S. R., Huang, J., Lipscomb, W. N. & van Poelje, P. D. (2007). J. Am. Chem. Soc. 129, 15480–15490. CrossRef PubMed CAS Google Scholar
Erion, M. D., van Poelje, P. D., Dang, Q., Kasibhatla, S. R., Potter, S. C., Reddy, M. R., Reddy, K. R., Jiang, T. & Lipscomb, W. N. (2005). Proc. Natl Acad. Sci. USA, 102, 7970–7975. CrossRef PubMed CAS Google Scholar
Gao, Y., Iancu, C. V., Mukind, S., Choe, J.-Y. & Honzatko, R. B. (2013). Biochemistry, 52, 5206–5216. CrossRef CAS PubMed Google Scholar
Geldern, T. W. von, Lai, C., Gum, R. J., Daly, M., Sun, C., Fry, E. H. & Abad-Zapatero, C. (2006). Bioorg. Med. Chem. Lett. 16, 1811–1815. PubMed Google Scholar
Gidh-Jain, M., Zhang, Y., van Poelje, P. D., Liang, J.-Y., Huang, S., Kim, J., Elliott, J. T., Erion, M. D., Pilkis, S. J., Raafat el-Maghrabi, M. & Lipscomb, W. N. (1994). J. Biol. Chem. 269, 27732–27738. CAS PubMed Web of Science Google Scholar
Gizak, A., Pirog, M. & Rakus, D. (2012). FEBS Lett. 586, 13–19. Web of Science CrossRef CAS PubMed Google Scholar
Harding, M. M., Nowicki, M. W. & Walkinshaw, M. D. (2010). Crystallogr. Rev. 16, 247–302. Web of Science CrossRef CAS Google Scholar
Hebeisen, P. et al. (2011). Bioorg. Med. Chem. Lett. 21, 3237–3242. CrossRef CAS PubMed Google Scholar
Hebeisen, P., Kuhn, B., Kohler, P., Gubler, M., Huber, W., Kitas, E., Schott, B., Benz, J., Joseph, C. & Ruf, A. (2008). Bioorg. Med. Chem. Lett. 18, 4708–4712. CrossRef PubMed CAS Google Scholar
Hines, J. K., Chen, X., Nix, J. C., Fromm, H. J. & Honzatko, R. B. (2007). J. Biol. Chem. 282, 36121–36131. CrossRef PubMed CAS Google Scholar
Iancu, C. V., Mukund, S., Fromm, H. J. & Honzatko, R. B. (2005). J. Biol. Chem. 280, 19737–19745. CrossRef PubMed CAS Google Scholar
Iversen, L. F., Brzozowski, M., Hastrup, S., Hubbard, R., Kastrup, J. S., Larsen, I. K., Naerum, L., Nørskov-Lauridsen, L., Rasmussen, P. B., Thim, L., Wiberg, F. C. & Lundgren, K. (1997). Protein Sci. 6, 971–982. CrossRef CAS PubMed Google Scholar
Karplus, P. A. & Diederichs, K. (2012). Science, 336, 1030–1033. Web of Science CrossRef CAS PubMed Google Scholar
Ke, H., Liang, J. Y., Zhang, Y. & Lipscomb, W. N. (1991). Biochemistry, 30, 4412–4420. CrossRef PubMed CAS Google Scholar
Ke, H., Thorpe, C. M., Seaton, B. A., Lipscomb, W. N. & Marcus, F. (1990). J. Mol. Biol. 212, 513–539. CrossRef CAS PubMed Web of Science Google Scholar
Ke, H., Thorpe, C. M., Seaton, B. A., Marcus, F. & Lipscomb, W. N. (1989). Proc. Natl Acad. Sci. USA, 86, 1475–1479. CrossRef CAS PubMed Web of Science Google Scholar
Ke, H., Zhang, Y., Liang, J.-Y. & Lipscomb, W. N. (1991). Proc. Natl Acad. Sci. USA, 88, 2989–2993. CrossRef PubMed CAS Web of Science Google Scholar
Ke, H., Zhang, Y. & Lipscomb, W. N. (1990). Proc. Natl Acad. Sci. USA, 87, 5243–5247. CrossRef CAS PubMed Web of Science Google Scholar
Kitas, E. et al. (2010). Bioorg. Med. Chem. Lett. 20, 594–599. CrossRef PubMed CAS Google Scholar
Lai, C., Gum, R. J., Daly, M., Fry, E. H., Hutchins, C., Abad-Zapatero, C. & von Geldern, T. W. (2006). Bioorg. Med. Chem. Lett. 16, 1807–1810. CrossRef PubMed CAS Google Scholar
Matthews, B. W. (1968). J. Mol. Biol. 33, 491–497. CrossRef CAS PubMed Web of Science Google Scholar
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C. & Read, R. J. (2007). J. Appl. Cryst. 40, 658–674. Web of Science CrossRef CAS IUCr Journals Google Scholar
Nelson, S. W., Honzatko, R. B. & Fromm, H. J. (2001). FEBS Lett. 492, 254–258. Web of Science CrossRef PubMed CAS Google Scholar
Otwinowski, Z. & Minor, W. (1997). Methods Enzymol. 276, 307–326. CrossRef CAS PubMed Web of Science Google Scholar
Padilla, J. E. & Yeates, T. O. (2003). Acta Cryst. D59, 1124–1130. Web of Science CrossRef CAS IUCr Journals Google Scholar
Pirog, M., Gizak, A. & Rakus, D. (2014). Int. J. Biochem. Cell Biol. 48, 55–59. CrossRef CAS PubMed Google Scholar
Read, R. J., Adams, P. D. & McCoy, A. J. (2013). Acta Cryst. D69, 176–183. Web of Science CrossRef CAS IUCr Journals Google Scholar
Rudolph, M. G., Wingren, C., Crowley, M. P., Chien, Y. & Wilson, I. A. (2004). Acta Cryst. D60, 656–664. Web of Science CrossRef CAS IUCr Journals Google Scholar
Shi, R., Chen, Z.-Y., Zhu, D.-W., Li, C., Shan, Y., Xu, G. & Lin, S.-X. (2013). PLoS One, 8, e71242. Web of Science CrossRef PubMed Google Scholar
Sliwiak, J., Dauter, Z., Kowiel, M., McCoy, A. J., Read, R. J. & Jaskolski, M. (2015). Acta Cryst. D71, 829–843. CrossRef IUCr Journals Google Scholar
Tsukada, T., Takahashi, M., Takemoto, T., Kanno, O., Yamane, T., Kawamura, S. & Nishi, T. (2009). Bioorg. Med. Chem. Lett. 19, 5909–5912. CrossRef PubMed CAS Google Scholar
Tsukada, T., Takahashi, M., Takemoto, T., Kanno, O., Yamane, T., Kawamura, S. & Nishi, T. (2010). Bioorg. Med. Chem. Lett. 20, 1004–1007. CrossRef CAS PubMed Google Scholar
Visinoni, S., Khalid, N. F., Joannides, C. N., Shulkes, A., Yim, M., Whitehead, J., Tiganis, T., Lamont, B. J., Favaloro, J. M., Proietto, J., Andrikopoulos, S. & Fam, B. C. (2012). Diabetes, 61, 1122–1132. CrossRef CAS PubMed Google Scholar
Weeks, C. M., Roszak, A. W., Erman, M., Kaiser, R., Jörnvall, H. & Ghosh, D. (1999). Acta Cryst. D55, 93–102. Web of Science CrossRef CAS IUCr Journals Google Scholar
Winn, M D. et al. (2011). Acta Cryst. D67, 235–242. Web of Science CrossRef CAS IUCr Journals Google Scholar
Word, J. M., Lovell, S. C., LaBean, T. H., Taylor, H. C., Zalis, M. E., Presley, B. K., Richardson, J. S. & Richardson, D. C. (1999). J. Mol. Biol. 285, 1711–1733. Web of Science CrossRef CAS PubMed Google Scholar
Wright, S. W. et al. (2002). J. Med. Chem. 45, 3865–3877. CrossRef PubMed CAS Google Scholar
Wright, S. W., Carlo, A. A., Danley, D. E., Hageman, D. L., Karam, G. A., Mansour, M. N., McClure, L. D., Pandit, J., Schulte, G. K., Treadway, J. L., Wang, I.-K. & Bauer, P. H. (2003). Bioorg. Med. Chem. Lett. 13, 2055–2058. CrossRef PubMed CAS Google Scholar
Xue, Y., Huang, S., Liang, J.-Y., Zhang, Y. & Lipscomb, W. N. (1994). Proc. Natl Acad. Sci. USA, 91, 12482–12486. CrossRef CAS PubMed Web of Science Google Scholar
Zarzycki, M., Kołodziejczyk, R., Maciaszczyk-Dziubinska, E., Wysocki, R., Jaskolski, M. & Dzugaj, A. (2011). Acta Cryst. D67, 1028–1034. Web of Science CrossRef IUCr Journals Google Scholar
Zwart, P. H., Afonine, P. V., Grosse-Kunstleve, R. W., Hung, L.-W., Ioerger, T. R., McCoy, A. J., McKee, E., Moriarty, N. W., Read, R. J., Sacchettini, J. C., Sauter, N. K., Storoni, L. C., Terwilliger, T. C. & Adams, P. D. (2008). Methods Mol. Biol. 426, 419–435. CrossRef PubMed CAS Google Scholar
Zwart, P. H., Grosse-Kunstleve, R. W., Lebedev, A. A., Murshudov, G. N. & Adams, P. D. (2008). Acta Cryst. D64, 99–107. Web of Science CrossRef CAS IUCr Journals Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.